SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
Gentherm entered into a Third Amended and Restated Credit Agreement on June 29, 2026, establishing a $550 million secured five-year revolving credit facility with customary covenants and financial maintenance requirements.
View raw filing on EDGAR →This Item 7.01 disclosure consists of a shareholder letter and FAQs providing operational and performance updates on Blue Owl Credit Income Corp., including portfolio performance metrics, tender offer results, capital inflows, and liquidity position. While the letter addresses material business matters (tender demand, shareholder retention, portfolio quality, and liquidity), the disclosure does not fit neatly into a specific event taxonomy category—it is neither a discrete governance action, financial obligation, operational milestone, nor legal/regulatory event, but rather a comprehensive investor communication. The domain is clearly financial/operational, but the nature is primarily informational rather than a triggering event, making `other_material` the most appropriate classification.
View raw filing on EDGAR →This is a CEO Investor Day presentation disclosing POSCO Holdings' comprehensive portfolio transformation strategy, extending from steel into lithium, critical materials, and energy. The document outlines material strategic initiatives including lithium production capacity expansion to 173Ktpa by 2033, overseas steel investments in India, USA, and Indonesia targeting 10Mtpa by 2031, LNG and renewable energy business development, and new business ventures in Physical AI and power infrastructure. While not a discrete transactional event, the strategic repositioning and capital allocation plans disclosed would materially affect a reasonable investor's assessment of the company's future direction and growth drivers.
View raw filing on EDGAR →The exhibit is a press release announcing a cash dividend declaration of US$0.87 per ordinary share for FY2025, with a payment date of July 28, 2026 to shareholders of record as of July 17, 2026. This is a straightforward dividend distribution disclosure that would be material to shareholders and investors assessing the company's capital allocation and shareholder returns.
View raw filing on EDGAR →The exhibit announces the closing of the Belly River light oil acquisition in the Wilson Creek area on June 30, 2026, for approximately $98 million. This is a material acquisition completion that adds 2,500 boe/d of production and 35 net sections of land, directly triggering Item 1.02 (Completion of Acquisition or Disposition of Assets) disclosure obligations. The transaction materially expands the company's asset base and production capacity.
View raw filing on EDGAR →The filing announces a monthly cash distribution of $0.429150 per unit payable to unitholders of the Sabine Royalty Trust. This is a routine but material distribution declaration typical of royalty trusts, disclosing the amount, record date, and payment date. The press release provides production volumes and commodity prices underlying the distribution, which is standard practice for trust distributions and material to unitholders.
View raw filing on EDGAR →Cameco announced a temporary suspension of mining operations at its Cigar Lake mine due to operational challenges at Orano's McClean Lake mill (sulfuric acid plant shutdown). While the company expects resumption within two weeks and does not currently expect impact to 2026 production, the disclosure explicitly acknowledges risk that repairs could take longer and potentially impact 2026 production outlook. This is a material operational disruption affecting a major production asset, though not fitting the specific categories of workforce reduction, material impairment, or covenant breach.
View raw filing on EDGAR →The filing announces a monthly distribution payable to shareholders of Vista Credit Strategic Lending Corp. for June 2026, specifying gross and net distribution amounts per share for each class of common stock ($0.15000 for Class I, $0.13667 net for Class S), with a record date of June 30, 2026 and payment date of approximately July 27, 2026. This is a routine but material dividend/distribution disclosure typical of closed-end funds and BDCs.
View raw filing on EDGAR →PIMCO Asset-Based Lending Co LLC completed an unregistered sale of LLC interests totaling approximately $44.7 million across multiple share classes to third-party investors on June 1, 2026, exempt under Section 4(a)(2) and Regulations D and S. This dilutive issuance materially affects existing shareholders' ownership percentages.
View raw filing on EDGAR →The company declared distributions on June 30, 2026, across multiple share classes with per-share amounts ranging from $0.0571 to $0.0936, payable on or about July 20, 2026. This regular capital return to shareholders is material to investors assessing yield and cash flow.
View raw filing on EDGAR →The disclosure reports a material regulatory and reimbursement development: the FDA reclassified non-invasive bone growth stimulators from Class III to Class II, CMS initially modified Medicare billing and fee schedules, but then withdrew those changes on July 1, 2026, restoring prior reimbursement rates. This is a significant operational and financial event affecting the Company's Medicare revenue for HCPCS codes E0747, E0748, and E0760, but it does not fit neatly into the specific financial or legal categories—it is a regulatory milestone with direct business impact that is best classified as an operational event.
View raw filing on EDGAR →The exhibit announces the appointment of Mr. Ying Tian as Chief Financial Officer of iQIYI, effective immediately. This is a material executive appointment to a named officer position (CFO), which would affect a reasonable investor's assessment of the company's financial leadership and governance. The concurrent step-down of Ms. Ying Zeng from Interim CFO is secondary to the principal appointment event.
View raw filing on EDGAR →Jonathan C. Korngold resigned from the Board of Directors effective June 30, 2026. The disclosure centers on a director's departure, not an appointment or compensation arrangement. While the resignation is characterized as amicable and unrelated to disagreement, board departures are material events affecting governance and investor assessment of the company's leadership composition.
View raw filing on EDGAR →The disclosure describes approval of the Xerox Holdings Corporation 2026–2028 Transformation Retention Award Plan, a compensatory arrangement for executive officers (including Named Executive Officers), senior leaders, and other employees. The Committee approved cash-based retention awards with specific vesting schedules and change-of-control provisions, which is a classic executive compensation disclosure under Item 5.02(e). This is material as it affects the total compensation structure and retention incentives for key executives during the company's transformation.
View raw filing on EDGAR →Cheniere Corpus Christi Holdings entered into a $1.0 billion Revolving Credit Agreement on June 26, 2026, for general corporate purposes and refinancing of existing working capital facilities, and amended its Term Loan Facility Agreement to extend the availability period for term loan disbursements. These arrangements create new and modified direct financial obligations material to the registrant's capital structure.
View raw filing on EDGAR →Analog Devices entered into a $3.0 billion Revolving Credit Facility on July 2, 2026, establishing a new direct financial obligation with customary covenants including a consolidated EBITDA-to-interest-charges ratio requirement of 3.00:1.00.
View raw filing on EDGAR →The Board declared a quarterly cash dividend of $0.075 per share payable on July 31, 2026 to stockholders of record on July 20, 2026.
View raw filing on EDGAR →Veru Inc. entered into an at-the-market (ATM) sales agreement on July 2, 2026, authorizing the issuance and sale of up to $21.8 million of common stock through Oppenheimer & Co. and Canaccord Genuity as sales agents. This is a registered equity offering under Form S-3 that creates potential dilution to existing shareholders and represents a material capital-raising activity typical of dilutive issuances.
View raw filing on EDGAR →Abivax entered into an Underwriting Agreement on June 30, 2026 for a public offering of 6,400,000 ADSs at $125.00 per ADS, generating approximately $759.8 million in net proceeds. While technically an equity issuance rather than debt, this represents a material capital-raising event that creates a direct financial obligation (the underwriting commitment) and substantially dilutes existing shareholders. The magnitude ($760M) and nature of the transaction (registered public offering) make it material to investors.
View raw filing on EDGAR →National Bankshares announced completion of a strategic portfolio restructuring involving the sale of $131.87 million in securities at a weighted average yield of 1.80% and purchase of $127.33 million in securities at 5.16%, resulting in a pre-tax loss of $6.55 million. While this is a material financial event affecting Q2 2026 earnings, it does not fit the specific categories of debt issuance, dividend distribution, material impairment, or restatement. The company characterizes this as a strategic repositioning to improve future yield, with the loss expected to be recovered over 1.8 years and offset by gains from a prior insurance subsidiary sale.
View raw filing on EDGAR →Item 5.07 discloses the results of World Kinect Corporation's June 18, 2026 Annual Meeting of Shareholders, including voting outcomes on three proposals: election of directors (all nominees elected), non-binding advisory vote on executive compensation (approved), and ratification of PricewaterhouseCoopers LLP as independent auditor (ratified). This is a standard shareholder vote results disclosure required under Item 5.07.
View raw filing on EDGAR →Third Coast Bancshares announced Board approval of a share repurchase program authorizing the Company to repurchase up to $30 million of common stock through June 30, 2027. Share repurchase programs are a form of capital return to shareholders and fall within the dividend_distribution category, which encompasses "share-repurchase programs" alongside dividends and distributions. The $30 million authorization and Federal Reserve notification indicate this is a material capital allocation decision.
View raw filing on EDGAR →Pyxis Oncology entered into a securities purchase agreement on June 30, 2026, to issue 19,600,153 shares of common stock at $2.551 per share plus warrants to purchase an equal number of shares at $3.289 per share, generating approximately $50 million in gross upfront proceeds with potential additional $64 million if warrants are exercised. This private placement significantly extends the company's cash runway into Q2 2027 and funds advancement of its lead clinical program.
View raw filing on EDGAR →The Board and Compensation Committee approved a discretionary cash bonus payment of $169,000 to Thomas J. Schaefer, CEO and Interim CFO, for services in 2025, with the updated 2025 Summary Compensation Table reflecting this compensatory arrangement.
View raw filing on EDGAR →The filing discloses an announcement of second quarter 2026 financial results to be released after market close on July 21, 2026, with a management conference call scheduled for July 22, 2026. The press release explicitly states that "Jeff Jackson, President and Chief Executive Officer, and Dan Weiss, Senior Executive Vice President and Chief Financial Officer, will review financial results for the second quarter of 2026." This is a standard earnings release announcement under Item 2.02, material to investors as it provides notice of upcoming quarterly financial disclosures.
View raw filing on EDGAR →The filing discloses a declared distribution to shareholders of Jefferies Credit Partners BDC Inc. for both Class I and Class S common shares, with specific per-share amounts ($0.1149 and $0.1045 respectively) payable on July 20, 2026. This is a routine but material dividend distribution typical of BDC (Business Development Company) operations, affecting shareholder returns and capital allocation.
View raw filing on EDGAR →The Company declared a monthly distribution of $0.15 per share payable on July 30, 2026 to shareholders of record as of July 22, 2026. This is a routine but material dividend distribution disclosure typical of closed-end funds, affecting shareholders' returns and investment value.
View raw filing on EDGAR →The disclosure reports exercise of warrants resulting in issuance of 13,619,377 shares of common stock to OC III LFE II, LP on June 30, 2026. This represents a substantial dilutive issuance that increased outstanding shares from an implied ~19.2 million to 32.8 million shares (approximately 71% dilution), materially affecting shareholder ownership and voting power. The magnitude and nature of the warrant exercise constitute a material capital event requiring disclosure under Item 8.01.
View raw filing on EDGAR →Senior Credit Investments, LLC declared a distribution of $16.7099 per Unit to unitholders, payable in cash on July 20, 2026. This is a direct distribution of capital to security holders, which is the core definition of a dividend_distribution event. The amount is material and would be relevant to investors evaluating the registrant's capital allocation and cash position.
View raw filing on EDGAR →The disclosure centers on the election of Tali Farhadian Weinstein to the Board of Directors of Consolidated Edison, Inc. and Consolidated Edison Company of New York, Inc., effective July 1, 2026. She was also appointed to two board committees. This is a clear board appointment, which is a material governance event affecting the composition of the registrant's leadership.
View raw filing on EDGAR →Jason R. Thackston, Senior Vice President of Growth, Energy Policy and External Relations, announced his retirement from Avista Corporation effective January 1, 2027. The disclosure centers on his departure from the company, with explicit confirmation that the departure is not due to disagreement with management or the Board. This is a clear executive departure event.
View raw filing on EDGAR →Cheniere entered into three material credit facility agreements on June 26, 2026: a Commitment Increase and Maturity Extension Agreement increasing its revolving credit facility by $500 million to $1.75 billion and extending maturity to August 1, 2031; a new $1.0 billion CCH Revolving Credit Agreement to refinance and support Corpus Christi liquefaction and pipeline operations; and a Second Amendment to the CCH Term Loan Facility Agreement extending the availability period for term loan disbursements.
View raw filing on EDGAR →Enanta Pharmaceuticals entered into an Open Market Sale Agreement with Jefferies LLC authorizing the sale of up to $75 million in common stock through an at-the-market (ATM) offering. This is a dilutive equity issuance that would materially affect existing shareholders through potential dilution and is a significant capital-raising event for the company.
View raw filing on EDGAR →The filing discloses termination of a material lease for the Company's Genetic Medicines Manufacturing Center (GMMC Facility), with associated costs of $1.75 million in forfeited security deposit plus $294,200 termination fee. While Item 1.02 typically covers termination of material definitive agreements, this is fundamentally an operational restructuring decision—the Company decommissioned the facility in 2025 to reduce costs and is outsourcing manufacturing to a contract manufacturer. The event is material to investors as it reflects a strategic shift in manufacturing operations and carries quantifiable financial consequences, but does not fit the specific categories of workforce_reduction, ma_activity, or financial_other as precisely as operational_other.
View raw filing on EDGAR →LivePerson entered into an Amended and Restated Merger Agreement on July 2, 2026, with SoundHound AI, Inc. and its subsidiaries (Merger Subs) to effect a merger whereby LivePerson will become an indirect wholly owned subsidiary of SoundHound. This is a material acquisition/change of control transaction involving the issuance of SoundHound Common Stock to LivePerson stockholders (except TASE Shares, which will receive cash consideration). The filing explicitly discloses the merger structure, consideration amounts, and closing conditions, all hallmarks of a material M&A activity disclosure under Item 1.01.
View raw filing on EDGAR →Erin Chapple voluntarily resigned as a member of the Board of Directors effective June 30, 2026. The disclosure explicitly states her departure was not due to disagreement with the Company, and the Board subsequently approved a reduction in board size from 11 to 10 directors. This is a clear executive departure event involving a director leaving office.
View raw filing on EDGAR →Core & Main issued $750 million of 6.000% Senior Notes due 2034 on July 1, 2026, pursuant to a new indenture. This is a material creation of a direct financial obligation. The filing also discloses a Sixth Amendment to the Term Loan Credit Agreement refinancing the 2028 Senior Term Loan with a new $800 million 2033 Senior Term Loan. Both transactions constitute debt issuances under Item 1.01, with the Notes being the primary new obligation disclosed.
View raw filing on EDGAR →The filing discloses receipt of an unsolicited, non-binding acquisition proposal from Omid Farokhzad, M.D., Seer's Chair and CEO, to acquire all outstanding shares of Class A common stock for $2.45 per share in cash plus two contingent value rights. This constitutes a material M&A activity event under Item 8.01, as it represents a potential change of control transaction that would materially affect the registrant and require board evaluation and stockholder consideration.
View raw filing on EDGAR →This is an ASX Appendix 2A application for quotation of 34,824 ordinary shares issued on vesting of 54,480 performance rights under an employee incentive scheme on 2–3 July 2026. While the immediate issuance is modest in absolute terms, it represents a dilutive equity event (conversion of unquoted performance rights into quoted ordinary shares) that increases the share count and would be material to a reasonable investor assessing capital structure and dilution. The document confirms the securities rank equally with existing ordinary shares and notes substantial unquoted convertible securities (45.2M convertible notes, 35M convertible debentures) that pose future dilution risk.
View raw filing on EDGAR →The Company entered into a Second Amendment to its Loan and Security Agreement, increasing the maximum facility amount from $250 million to $400 million (with accordion feature to $450 million), reducing the applicable margin, and extending key maturity dates. Additionally, total commitments under the SMBC Revolving Credit Facility were increased from $650 million to $675 million on June 30, 2026, representing material expansions of the Company's direct financial obligations and borrowing capacity.
View raw filing on EDGAR →ITG, Inc. entered into material definitive agreements in connection with its initial public offering (IPO), including an Underwriting Agreement, Tax Receivable Agreement, Stockholders Agreement, and Registration Rights Agreement. The IPO represents a material change of control and capital event that significantly affects investor assessment of the registrant.
View raw filing on EDGAR →ITG, Inc. completed an initial public offering on July 2, 2026, issuing 19,512,196 shares of Class A Common Stock at $16.00 per share, with underwriters exercising an option to purchase an additional 2,926,829 shares. The proceeds were used to purchase LLC interests from ITG Parent, which then repaid debt facilities.
View raw filing on EDGAR →ITG, Inc. issued over 101 million shares of Class A and Class B Common Stock to Oaktree Blocked Fund, Oaktree Aggregator, and ITG Management Holdings, LLC on July 1, 2026, in reliance on Section 4(a)(2) exemption from Securities Act registration as part of a restructuring or recapitalization transaction.
View raw filing on EDGAR →Francis A. Braun III and Dylan G. Petre were appointed to the Board of Directors effective July 1, 2026 upon listing, with Braun designated as Audit Committee chair and Petre appointed to the Nominating and Corporate Governance Committee.
View raw filing on EDGAR →ITG, Inc. modified security holder rights through a Registration Rights Agreement and related amendments, affecting shareholders' ability to liquidate holdings and other governance matters in connection with the IPO.
View raw filing on EDGAR →Arcturus entered into a material strategic collaboration with Thermo Fisher Scientific on June 26, 2026, comprising a Master Services Agreement and Project Addendum for CDMO and CRO services for ARCT-032 (cystic fibrosis therapy). The transaction includes up to $40 million in clinical manufacturing services and $40 million in CRO services, with Thermo Fisher receiving exclusive commercial manufacturing rights upon regulatory approval.
View raw filing on EDGAR →Polibeli Group entered into a non-binding memorandum of understanding with AUTHAIKAM COMPANY LIMITED on June 30, 2026, to evaluate a potential AI computing center opportunity in Thailand with planned power capacity of up to 100 MW. While the MOU is non-binding and the project remains at preliminary evaluation stage with no capital commitment yet, the disclosure of a strategic expansion into AI infrastructure in a new jurisdiction represents a material operational and strategic business development that would affect a reasonable investor's assessment of the company's growth trajectory and business direction.
View raw filing on EDGAR →Vaxart entered into a Cooperation Agreement with a stockholder group that resolves a proxy contest through comprehensive governance enhancements, including the appointment of a mutually agreed independent director, formation of new board committees (Stockholder Engagement and Clinical and Regulatory Affairs), adoption of director stock ownership and resignation policies, and quarterly management engagement.
View raw filing on EDGAR →This press release announces a strategic repositioning of POMDOCTOR from a traditional online healthcare platform toward an AI-enabled predictive healthcare infrastructure provider. The announcement describes a significant business model evolution integrating wearable technologies, AI analytics, physician services, and healthcare payment networks. While this is a strategic business announcement rather than a discrete operational event (like a contract, partnership, or regulatory milestone), it represents a material shift in the company's strategic direction and business positioning that would affect a reasonable investor's assessment of the company's future prospects and competitive positioning.
View raw filing on EDGAR →Yiren Digital's board has authorized a new share repurchase program permitting the company to repurchase up to 10% of outstanding shares for up to $20 million over the next 12 months. Share repurchase programs are a form of capital return to shareholders and fall within the dividend_distribution category, which encompasses "share-repurchase programs." The $20 million authorization and 10% share cap represent a material capital allocation decision that would affect a reasonable investor's assessment of the company's capital strategy and shareholder returns.
View raw filing on EDGAR →